Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 2,137 Jan 1 – Oct 9, 2026
- Disclosed funding
- $200.7B 1769 disclosed amounts
- Median round
- $24M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| P Provides AI-powered process optimization solutions for manufacturers | Undisclosed | Seed | Industrial tech | United States | Investors | |
 ActivelyCompany profile AI account agents that research prospects, maintain account context and advance work for revenue teams. AI account agents that research prospects, maintain account context and advance work for revenue teams. | $45M | Series B | AI | United States | Investors | |
| M Provides software-based security for payments, identity, and digital assets | Undisclosed | Undisclosed | Cybersecurity | United States | Investors | |
| LP Lighthouse PharmaceuticalsCompany profile Develops novel small-molecule therapies for neurodegenerative and inflammatory diseases Develops novel small-molecule therapies for neurodegenerative and inflammatory diseases | $12M | Series A | Biotech | United States | Investors | |
| L Provides a single trading platform for crypto and traditional assets, 24/7 | $18M | Seed | Fintech | United States | Investors | |
| C Provides AI platform for enterprise travel and expense management | $11.5M | Series A | AI | United States | Investors | |
| X X-energyCompany profile X-energy develops small modular nuclear reactors and TRISO fuel for electricity and industrial energy. X-energy develops small modular nuclear reactors and TRISO fuel for electricity and industrial energy. | ~$1.1B | IPO (net proceeds)Undisclosed | Climate tech | United States | Investors Undisclosed | |
| FT Uses quantum chemistry and AI to design novel drug molecules | $47M | Series A | Biotech | United States | Investors | |
| N NervonikCompany profile Develops peripheral nerve stimulation technologies for chronic pain and neurological conditions Develops peripheral nerve stimulation technologies for chronic pain and neurological conditions | $52.5M | Series B | Healthtech | United States | Investors | |
| S Develops an AI-powered homescreen app for iPhone | $3.6M | Pre-SeedPre-seed | AI | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Nous Research, Santé, Vitalize
126rounds3led - 2Andreessen Horowitz (a16z)
TypeSafe AI, Arena, Vesta
94rounds18led - 3General Catalyst
Minerva Humanoids, Melius
65rounds6led - 4Alumni Ventures
Savvy Wealth, Ocular AI, Mona
56rounds0led - 5Khosla Ventures
Arena, Vinci, Conway Research
54rounds5led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.